Ephedrine and its salts in combination products
in preparations containing no more than 8 mg per unit dose, with a label recommending no more than 8 mg/dose or 32 mg/day and for use not more than 7 days, and indicated for nasal congestion.
Approval Date: April 23, 2006
Schedule: III
Footnote:
